Serial therapies oriented by surgery for large primary liver carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 3, 2002, Pages 411-415

  Rui, Jing An ^a   Wang, Shao Bin ^a   Chen, Shu Guang ^a   Zhou, Li ^a   Wei, Xue ^a   Han, Kai ^a   Zhang, Ning ^a   Zhao, Hai Tao ^a   Yang, Xin ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

AFPmRNA; Aromatic amino acid; Branch chain amino acid; Cryosurgery; Large primary liver carcinoma; Resection; Survival

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; AROMATIC AMINO ACID; BIOLOGICAL FACTOR; BRANCHED CHAIN AMINO ACID; CISPLATIN; EPIRUBICIN; FLUOROURACIL; INTERLEUKIN 2; KANGLAITE; LENTINAN; MITOMYCIN C; PIRARUBICIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHINESE MEDICINE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRYOSURGERY; DISEASE CLASSIFICATION; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LIVER CARCINOMA; LIVER FAILURE; LIVER FUNCTION; LIVER NODULE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PORTAL PHLEBOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; AMINO ACIDS, AROMATIC; AMINO ACIDS, BRANCHED-CHAIN; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; CRYOSURGERY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 0037973431     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wu MC. Progress in diagnosis and treatment of primary liver cancer. Chin J Surg 1998;36:515-518.
2. Shuto T, Hirohashi K, Kubo S, et al. Efficacy of major hepatic resection for large hepatocellular carcinoma. Hepatogastroenterology 1999;46:413-416.
3. Regimbeau JM, Farges O, Shen BY, et al. Is surgery for large hepatocellular carcinoma justified? J Hepatol 1999;31:1062-1068.
4. Hanazaki K, Kajikawa S, Shimozawa N, et al. Hepatic resection for large hepatocellular carcinoma. Am J Surg 2001; 181:347-353.
5. American Joint Committee on Cancer (AJCC). AJCC cancer staging manual. 5th ed. New York: Lippincott-Raven. 1997,97-101.
6. Liu YH, Zhou RL, Rui JA. A detection of hepatoma cells in peripheral blood of the patients with HCC with nested RT-PCR. J Beijing Med Univ 1997;29:270-272.
7. Rui JA, Wang K, Su Y, et al. Right trisegmentectomy for primary liver cancer. Chin J Oncol 1991; 13: 37-39.
8. Rui JA, Qu JY, Su Y, et al. Hemihepatectomy under hepato-portal interruption at normal temperature for liver malignancies. Chin J Oncol 1987;9:221-223.
9. Zhou XD. Cryosurgery for primary hepatic cancer of 87 patients. Chin J Surg 1992;30:334-336,381.
10. Wang SB, Rui JA, Chi TY, et al. Cryosurgery for primary liver cancer. Chin J Gen Surg 1997;12:285 -286.
11. Wei X, Rui JA, Wang SB, et al. Cryosurgery for liver cancer: experience in treating 57 patients. J Hepatobiliary Surg 1998;6:282-284.
12. Han K, Wang SB, Zhang N, et al. Portal vein tumor thrombosis treated by implanted drug delivery system with 64 cases report. Morden Surg 1999;5:13-14.
13. Wang SB, Lin M, Rui JA, et al. A study on the clinical significance of serum profile of amino acids in 55 patients with primary liver cancer. Chin J Gen Surg 1997;12:259.